Analysis by Goldman Sachs
Goldman Sachs has lowered the price target for Symrise stock from €126 to €106, while keeping the rating at “Neutral.” This change reflects the deteriorating economic conditions affecting the European chemical industry.
The Symrise stock was trading at approximately €93.38 on XETRA, indicating a slight decline. The trading volume was relatively low at 53,617 shares. Despite the reduced price targets, the stock offers an upside potential of about 13.51 percent at a price target of €106.
Comparison with Other Analyses
In contrast to Goldman Sachs, Warburg Research rates the stock as “Buy” with a price target of €117.50, suggesting higher potential as the stock has fallen by 12.5 percent since the beginning of 2025.
Other institutions such as JP Morgan and Baader Bank rate Symrise as “Overweight” and “Add” respectively. These positive ratings indicate a more optimistic view on the company’s future developments.
Company Development and Market Situation
The chemical industry faces challenges due to the current economic situation, which is reflected in the lowered price targets. Nevertheless, Symrise remains an important player in the specialty chemicals sector.
Technical indicators like the Relative Strength Index (RSI) and the Stochastic Oscillator could provide insight into future price movements. A high RSI value of 70 may indicate overbought conditions, while a Stochastic value of 84 suggests strong price momentum.
Conclusion for Investors
Goldman Sachs provides a neutral assessment of Symrise stock. Other analysts such as Warburg Research and JP Morgan are more optimistic. Investors should consider the various ratings and the current market situation to make informed decisions. Symrise stock still has upside potential; however, the current economic situation should be closely monitored.